Mindfulness Meditation for Health
Primary Purpose
Alcohol Dependence
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Mindfulness Based Relapse Prevention for Alcohol Dependence
"Wait-list" control
Sponsored by
About this trial
This is an interventional treatment trial for Alcohol Dependence focused on measuring Alcohol Dependence, Alcoholism, Substance Use Disorders, Substance Abuse
Eligibility Criteria
Inclusion Criteria:
- Alcohol dependence diagnosis
- Completed at least 2 weeks of IOP or (IOP equivalent=at least 2 days per week) for alcohol dependence
- Sober since beginning of outpatient treatment
- English fluency; ability to fill out surveys
- Permanent home address and telephone
- At least 18 years old
- Score >13 on the Perceived Stress Scale
Exclusion Criteria:
- Pregnant
- Alcohol abstinence >14 weeks before enrollment
- Current, regular meditation
- Pre-existing bipolar, schizophrenia, or delusional disorder
- Regular drug use (other than tobacco) in last 2 weeks
- Inability to reliably participate
Sites / Locations
- University of Wisconsin-Madison
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Meditation
Wait-list control
Arm Description
Mindfulness Based Relapse Prevention for Alcohol Dependence intervention + Standard of Care therapy
Standard of Care therapy only
Outcomes
Primary Outcome Measures
Percent Heavy Drinking Days
Alcohol consumption as measured by percent heavy drinking days from baseline to 26 weeks. A heavy drinking day is defined as 4 or more drinks for women or 5 or more drinks for men, during a 24-hour period.
Percent Days Abstinent From Alcohol
Measures percent days abstinent from alcohol
Time to Relapse (Resumption of Drinking)
Alcohol consumption as measured by time to relapse (resumption of drinking) from baseline to 26 weeks.
Secondary Outcome Measures
Drinker Inventory of Consequences
Severity of drinking related negative consequences as measured by the Drinker Inventory of Consequences (DrInC-2R). This inventory consists of 50 items rated on a scale of 0 to 3, with '0' indicating a given consequence did not happen, '1' indicating it almost happened, '2' indicating it did happen, and '3' indicating it happened more than once. The sum of all ratings (minus the 5 control questions) indicates the 'total score', with higher scores corresponding to more drinking related consequences. The 'total score' can range from 0 (did not happen) to 135 (happened all the time).
Subject Treatment Satisfaction
Treatment satisfaction rating on a Likert scale of 1 to 7 (1 indicating 'extremely dissatisfied', 4 'neutral', and 7 'extremely satisfied').
Subject Treatment Adherence
Mindfulness Based Relapse Prevention for Alcohol Dependence intervention session attendance; adherence defined as attending 4 or more out of 8 total sessions.
Full Information
NCT ID
NCT01056484
First Posted
January 22, 2010
Last Updated
October 24, 2014
Sponsor
University of Wisconsin, Madison
Collaborators
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)
1. Study Identification
Unique Protocol Identification Number
NCT01056484
Brief Title
Mindfulness Meditation for Health
Official Title
Mindfulness Meditation For Alcohol Relapse Prevention
Study Type
Interventional
2. Study Status
Record Verification Date
October 2014
Overall Recruitment Status
Completed
Study Start Date
September 2009 (undefined)
Primary Completion Date
May 2013 (Actual)
Study Completion Date
May 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Wisconsin, Madison
Collaborators
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this 52-week clinical trial is to see if the meditation-based intervention, adjunctive to standard of care therapy, can reduce relapse and improve psychological health among adults recovering from alcohol dependence.
Detailed Description
The goal of this partially-blinded, two-arm clinical trial was to test whether the Mindfulness Meditation Relapse Prevention (meditation), combined with 'standard of care' (SOC) therapy, is more effective in preventing a return to drinking than SOC alone (wait-list control) among adult recovering alcoholics. The intervention was manualized and based on existing models. It was proposed that meditation may improve outcomes of interest through reduction of the severity of stress-related relapse risk factors such as perceived stress, anxiety, depression, craving and emotion dysregulation, and the level of stress-sensitive biomarkers (cytokine interleukin-6, liver enzymes).
For this study, 123 adult alcohol dependent subjects were recruited from collaborating treatment centers, randomly assigned to one of two equal study arms, and followed for 26-weeks (Period 1, Randomized Controlled Trial, RCT). The RCT evaluated the efficacy of the meditation intervention using self-reported alcohol consumption as primary, and drinking-related harms and subject treatment satisfaction and adherence as secondary outcomes. It also gathered preliminary data on potential mechanisms of meditation action. After the completion of their 26-week RCT (Period 1), controls were eligible to receive the meditation intervention ("cross-over"), and all participants were followed-up for additional 26 weeks (non-randomized Period 2).
This study will provide evidence about the efficacy of meditation for alcohol relapse prevention, will further our understanding of relapse and the potential mechanisms of meditation action, direct future research and guide clinical decision-making.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol Dependence
Keywords
Alcohol Dependence, Alcoholism, Substance Use Disorders, Substance Abuse
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
123 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Meditation
Arm Type
Experimental
Arm Description
Mindfulness Based Relapse Prevention for Alcohol Dependence intervention + Standard of Care therapy
Arm Title
Wait-list control
Arm Type
Other
Arm Description
Standard of Care therapy only
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness Based Relapse Prevention for Alcohol Dependence
Other Intervention Name(s)
Mindfulness Meditation, Meditation, Mindfulness, Relapse Prevention
Intervention Description
All subjects receive outpatient standard of care (SOC) therapy for alcohol dependence. Experimental subjects also receive the Mindfulness Meditation Relapse Prevention ('meditation') intervention. The intervention is an extension of existing meditation-based therapies for stress, relapse prevention in addictive disorders, and depression. It has been patterned after Mindfulness Based Relapse Prevention and tailored to the specific needs of alcoholics. Its curriculum includes both meditation and "traditional" cognitive therapy relapse prevention components. The intervention consists of an 8-week, manualized meditation course (2 hours/week group sessions) guided by trained instructors. In addition, experimental subjects are asked to meditate at-home (30 min/day, 6 days/week) during the study.
Intervention Type
Other
Intervention Name(s)
"Wait-list" control
Other Intervention Name(s)
Standard of Care, Treatment as Usual
Intervention Description
'Standard of care' (SOC) outpatient therapy for alcohol dependence is provided to all subjects through their outpatient treatment centers and as recommended by their regular providers. Subjects in the control group receive SOC only. Subjects in the experimental arm will receive the study meditation intervention in addition to SOC.
Primary Outcome Measure Information:
Title
Percent Heavy Drinking Days
Description
Alcohol consumption as measured by percent heavy drinking days from baseline to 26 weeks. A heavy drinking day is defined as 4 or more drinks for women or 5 or more drinks for men, during a 24-hour period.
Time Frame
26 weeks
Title
Percent Days Abstinent From Alcohol
Description
Measures percent days abstinent from alcohol
Time Frame
26 weeks
Title
Time to Relapse (Resumption of Drinking)
Description
Alcohol consumption as measured by time to relapse (resumption of drinking) from baseline to 26 weeks.
Time Frame
26 weeks
Secondary Outcome Measure Information:
Title
Drinker Inventory of Consequences
Description
Severity of drinking related negative consequences as measured by the Drinker Inventory of Consequences (DrInC-2R). This inventory consists of 50 items rated on a scale of 0 to 3, with '0' indicating a given consequence did not happen, '1' indicating it almost happened, '2' indicating it did happen, and '3' indicating it happened more than once. The sum of all ratings (minus the 5 control questions) indicates the 'total score', with higher scores corresponding to more drinking related consequences. The 'total score' can range from 0 (did not happen) to 135 (happened all the time).
Time Frame
26 weeks
Title
Subject Treatment Satisfaction
Description
Treatment satisfaction rating on a Likert scale of 1 to 7 (1 indicating 'extremely dissatisfied', 4 'neutral', and 7 'extremely satisfied').
Time Frame
8 weeks
Title
Subject Treatment Adherence
Description
Mindfulness Based Relapse Prevention for Alcohol Dependence intervention session attendance; adherence defined as attending 4 or more out of 8 total sessions.
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Alcohol dependence diagnosis
Completed at least 2 weeks of IOP or (IOP equivalent=at least 2 days per week) for alcohol dependence
Sober since beginning of outpatient treatment
English fluency; ability to fill out surveys
Permanent home address and telephone
At least 18 years old
Score >13 on the Perceived Stress Scale
Exclusion Criteria:
Pregnant
Alcohol abstinence >14 weeks before enrollment
Current, regular meditation
Pre-existing bipolar, schizophrenia, or delusional disorder
Regular drug use (other than tobacco) in last 2 weeks
Inability to reliably participate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aleksandra Zgierska, MD PhD
Organizational Affiliation
University of Wisconsin, Madison
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Wisconsin-Madison
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53705
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
19904664
Citation
Zgierska A, Rabago D, Chawla N, Kushner K, Koehler R, Marlatt A. Mindfulness meditation for substance use disorders: a systematic review. Subst Abus. 2009 Oct-Dec;30(4):266-94. doi: 10.1080/08897070903250019.
Results Reference
background
PubMed Identifier
21768988
Citation
Zgierska A, Rabago D, Zuelsdorff M, Coe C, Miller M, Fleming M. Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. J Addict Med. 2008 Sep;2(3):165-73. doi: 10.1097/ADM.0b013e31816f8546.
Results Reference
background
PubMed Identifier
19904663
Citation
Marcus MT, Zgierska A. Mindfulness-based therapies for substance use disorders: part 1. Subst Abus. 2009 Oct-Dec;30(4):263-5. doi: 10.1080/08897070903250027. No abstract available.
Results Reference
background
Links:
URL
http://www.fammed.wisc.edu/research/external-funded/alcohol-prevention
Description
brief description of the findings from the pilot study
Learn more about this trial
Mindfulness Meditation for Health
We'll reach out to this number within 24 hrs